Literature DB >> 20463064

Functional analysis of the influenza virus H5N1 nucleoprotein tail loop reveals amino acids that are crucial for oligomerization and ribonucleoprotein activities.

Wai-Hon Chan1, Andy Ka-Leung Ng, Nicole C Robb, Mandy Ka-Han Lam, Paul Kay-Sheung Chan, Shannon Wing-Ngor Au, Jia-Huai Wang, Ervin Fodor, Pang-Chui Shaw.   

Abstract

Homo-oligomerization of the nucleoprotein (NP) of influenza A virus is crucial for providing a major structural framework for the assembly of viral ribonucleoprotein (RNP) particles. The nucleoprotein is also essential for transcription and replication during the virus life cycle. In the H5N1 NP structure, the tail loop region is important for NP to form oligomers. Here, by an RNP reconstitution assay, we identified eight NP mutants that had different degrees of defects in forming functional RNPs, with the RNP activities of four mutants being totally abolished (E339A, V408S P410S, R416A, and L418S P419S mutants) and the RNP activities of the other four mutants being more than 50% decreased (R267A, I406S, R422A, and E449A mutants). Further characterization by static light scattering showed that the totally defective protein variants existed as monomers in vitro, deviating from the trimeric/oligomeric form of wild-type NP. The I406S, R422A, and E449A variants existed as a mixture of unstable oligomers, thus resulting in a reduction of RNP activity. Although the R267A variant existed as a monomer in vitro, it resumed an oligomeric form upon the addition of RNA and retained a certain degree of RNP activity. Our data suggest that there are three factors that govern the NP oligomerization event: (i) interaction between the tail loop and the insertion groove, (ii) maintenance of the tail loop conformation, and (iii) stabilization of the NP homo-oligomer. The work presented here provides information for the design of NP inhibitors for combating influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463064      PMCID: PMC2898228          DOI: 10.1128/JVI.02474-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle.

Authors:  J Martín-Benito; E Area; J Ortega; O Llorca; J M Valpuesta; J L Carrascosa; J Ortín
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

2.  Oligomerization of the influenza virus nucleoprotein: identification of positive and negative sequence elements.

Authors:  D Elton; E Medcalf; K Bishop; P Digard
Journal:  Virology       Date:  1999-07-20       Impact factor: 3.616

3.  Crystal structure of the rabies virus nucleoprotein-RNA complex.

Authors:  Aurélie A V Albertini; Amy K Wernimont; Tadeusz Muziol; Raimond B G Ravelli; Cedric R Clapier; Guy Schoehn; Winfried Weissenhorn; Rob W H Ruigrok
Journal:  Science       Date:  2006-06-15       Impact factor: 47.728

4.  Architecture of ribonucleoprotein complexes in influenza A virus particles.

Authors:  Takeshi Noda; Hiroshi Sagara; Albert Yen; Ayato Takada; Hiroshi Kida; R Holland Cheng; Yoshihiro Kawaoka
Journal:  Nature       Date:  2006-01-26       Impact factor: 49.962

5.  Structure of the vesicular stomatitis virus nucleoprotein-RNA complex.

Authors:  Todd J Green; Xin Zhang; Gail W Wertz; Ming Luo
Journal:  Science       Date:  2006-06-15       Impact factor: 47.728

6.  The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA.

Authors:  Qiaozhen Ye; Robert M Krug; Yizhi Jane Tao
Journal:  Nature       Date:  2006-12-06       Impact factor: 49.962

Review 7.  Emerging antiviral targets for influenza A virus.

Authors:  Robert M Krug; James M Aramini
Journal:  Trends Pharmacol Sci       Date:  2009-05-08       Impact factor: 14.819

8.  Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein.

Authors:  Zejun Li; Tokiko Watanabe; Masato Hatta; Shinji Watanabe; Asuka Nanbo; Makoto Ozawa; Satoshi Kakugawa; Masayuki Shimojima; Shinya Yamada; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

9.  Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design.

Authors:  Andy Ka-Leung Ng; Hongmin Zhang; Kemin Tan; Zongli Li; Jin-huan Liu; Paul Kay-Sheung Chan; Sui-Mui Li; Wood-Yee Chan; Shannon Wing-Ngor Au; Andrzej Joachimiak; Thomas Walz; Jia-Huai Wang; Pang-Chui Shaw
Journal:  FASEB J       Date:  2008-07-09       Impact factor: 5.191

Review 10.  Structure and sequence analysis of influenza A virus nucleoprotein.

Authors:  Andy Ka-Leung Ng; Jia-Huai Wang; Pang-Chui Shaw
Journal:  Sci China C Life Sci       Date:  2009-05-27
View more
  34 in total

1.  E339...R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitors.

Authors:  Yu-Fang Shen; Yu-Hou Chen; Shao-Ying Chu; Meng-I Lin; Hua-Ting Hsu; Pei-Yu Wu; Chao-Jung Wu; Hui-Wen Liu; Fu-Yang Lin; Gialih Lin; Pang-Hung Hsu; An-Suei Yang; Yih-Shyun E Cheng; Ying-Ta Wu; Chi-Huey Wong; Ming-Daw Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Sequence in the influenza A virus nucleoprotein required for viral polymerase binding and RNA synthesis.

Authors:  Jesper K Marklund; Qiaozhen Ye; Jinhui Dong; Yizhi Jane Tao; Robert M Krug
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Replication-coupled and host factor-mediated encapsidation of the influenza virus genome by viral nucleoprotein.

Authors:  Atsushi Kawaguchi; Fumitaka Momose; Kyosuke Nagata
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

4.  Stabilization of influenza virus replication intermediates is dependent on the RNA-binding but not the homo-oligomerization activity of the viral nucleoprotein.

Authors:  Frank T Vreede; Andy Ka-Leung Ng; Pang-Chui Shaw; Ervin Fodor
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

5.  Pre-mRNA Processing Factor Prp18 Is a Stimulatory Factor of Influenza Virus RNA Synthesis and Possesses Nucleoprotein Chaperone Activity.

Authors:  M Minakuchi; K Sugiyama; Y Kato; T Naito; M Okuwaki; A Kawaguchi; K Nagata
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

Review 6.  Recent progress in structure-based anti-influenza drug design.

Authors:  Juan Du; Timothy A Cross; Huan-Xiang Zhou
Journal:  Drug Discov Today       Date:  2012-06-13       Impact factor: 7.851

7.  Identification of two functional domains within the arenavirus nucleoprotein.

Authors:  Jesica M Levingston Macleod; Alejandra D'Antuono; Maria Eugenia Loureiro; Juan Cruz Casabona; Guillermo A Gomez; Nora Lopez
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

8.  Structural basis for RNA binding and homo-oligomer formation by influenza B virus nucleoprotein.

Authors:  Andy Ka-Leung Ng; Mandy Ka-Han Lam; Hongmin Zhang; Jinhuan Liu; Shannon Wing-Ngor Au; Paul Kay-Sheung Chan; Jiahuai Wang; Pang-Chui Shaw
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

9.  Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.

Authors:  Nathalie Lejal; Bogdan Tarus; Edwige Bouguyon; Sylvie Chenavas; Nicolas Bertho; Bernard Delmas; Rob W H Ruigrok; Carmelo Di Primo; Anny Slama-Schwok
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

10.  Mutations to PB2 and NP proteins of an avian influenza virus combine to confer efficient growth in primary human respiratory cells.

Authors:  Shamika Danzy; Lydia R Studdard; Balaji Manicassamy; Alicia Solorzano; Nicolle Marshall; Adolfo García-Sastre; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.